We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

4182:TSEMitsubishi Gas Chemical Company, Inc. Analysis

Data as of 2026-06-17 - not real-time

¥5,103.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Mitsubishi Gas Chemical (4182.T) is trading around ¥5,103, comfortably above its 20‑day SMA (~¥5,097) and the 50‑day SMA (~¥4,669), confirming a bullish price structure despite a bearish MACD histogram. The RSI sits near 55, indicating neither overbought nor oversold conditions, while the low beta of ~0.25 suggests limited market‑wide volatility, even though the 30‑day price volatility is high at roughly 65%. Recent momentum has cooled after a strong 10% three‑month rally, and the stock now hovers near a key support level of ¥4,200 with resistance around ¥5,626.
Fundamentally, the company posted a negative profit margin (-5.5%) and a trailing EPS loss, but forward EPS is projected positive, driving a forward P/E of about 18.5. The DCF fair‑value estimate of ¥2,744 is far below the current price, flagging the stock as overvalued, yet analysts maintain a “buy” consensus with a median target of ¥5,300. A dividend yield of 2.16% and a moderate payout ratio (~41%) provide income appeal, though free cash flow remains negative and debt‑to‑equity is elevated at 33, underscoring financial risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price consolidation near support after recent rally
  • Bearish MACD histogram indicating potential pullback
  • Stable volume and low beta limiting short‑term downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Projected earnings turnaround with positive forward EPS
  • Attractive dividend yield and moderate payout ratio
  • Bullish trend above key moving averages and upside to resistance

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Significant valuation gap between market price and DCF fair value
  • High debt level and negative free cash flow raising financial risk
  • Steady dividend income and low beta supporting a defensive profile

Key Metrics & Analysis

Financial Health

Revenue Growth-0.90%
Profit Margin-5.46%
P/E Ratio18.5
ROE-4.96%
ROA2.42%
Debt/Equity33.00
P/B Ratio1.5
Op. Cash Flow¥74.7B
Free Cash Flow¥-24430125056

Technical Analysis

TrendBullish
RSI55.5
Support¥4,200.00
Resistance¥5,626.00
MA 20¥5,097.30
MA 50¥4,668.74
MA 200¥3,520.86
MACDBearish
VolumeStable
Fear & Greed Index92.13

Valuation

Fair Value¥2,743.83
Target Price¥5,060.00
Upside/Downside-0.84%
GradeOvervalued
TypeBlend
Dividend Yield2.16%

Risk Assessment

Beta0.25
Volatility65.08%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.